Sterling Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.94M | Sell |
12,089
-1,008
| -8% | -$329K | 0.06% | 234 |
|
|
2025
Q1 | $3.54M | Sell |
13,097
-4,990
| -28% | -$1.35M | 0.05% | 236 |
|
|
2024
Q4 | $4.26M | Buy |
18,087
+15,507
| +601% | +$3.65M | 0.06% | 254 |
|
|
2024
Q3 | $710K | Buy |
+2,580
| New | +$710K | 0.01% | 704 |
|
|
2015
Q3 | – | Sell |
-9,205
| Closed | -$1.1M | – | 961 |
|
|
2015
Q2 | $1.1M | Sell |
9,205
-334
| -4% | -$40K | 0.01% | 429 |
|
|
2015
Q1 | $996K | Buy |
+9,539
| New | +$996K | 0.01% | 449 |
|